Matt is a Virscio co-founder and is responsible for design and execution of Virscio’s preclinical programs and associated alignment of team expertise and capabilities to ensure efficient translation of sponsor programs to meet development objectives. Matt has over thirty years of experience in nonhuman primate research and over fifteen years of experience designing, executing and leading industry and NIH funded R&D programs that leverage Virscio’s translational platform to de-risk promising therapeutic candidates. Matt has been instrumental in the design and execution of preclinical programs for a wide range of academic groups, venture-backed start-ups, and publicly traded biotechnology and pharmaceutical companies. Matt received a BA in Biology and Geology from Harvard College, PhD in Neuroscience from Stanford University as a Howard Hughes Medical Institute Predoctoral Fellow, and MD from Yale School of Medicine. Matt completed his internship in medicine at the University of Hawaii and ophthalmology residency at Massachusetts Eye and Ear Infirmary and is an Aspen Institute Health Innovators Fellow.